Treatment of fatty liver from the spleen start with?
Fatty liver is generally considered benign lesions, prognosis is good. But that the development of fatty liver can be directly through the development of liver inflammation fibrosis, about 25% of the final development of fatty liver hepatitis fibrosis.
I since July 1997 to May 2000, using spleen Shugan treating 42 patients with fatty liver, and achieved better effect. A total of 82 cases observed were randomly divided into treatment group and control group, treatment group, 42 cases in the control group of 40 patients. 82 cases of patients who were prompted by B-ultrasound showed fatty liver change, 81 cases had varying degrees of hyperlipidemia, 23 patients with elevated alanine aminotransferase.
The diagnosis of fatty liver is currently still a lack of specific biochemical markers, in theory, liver biopsy is the most direct and accurate diagnostic methods, but patients with clinically difficult to accept. Some scholars believe that the recent simple fatty liver and steatohepatitis has been very little reliance on the diagnosis of liver biopsy, moderate or severe fatty liver ultrasound diagnostic sensitivity of up to 90%, in non-fibrosis of the liver, ultrasound diagnosis of fatty liver of sensitive of up to 100%, B super-fatty liver is now available as the preferred diagnostic method. Therefore, we see the B-check the distribution of the liver-spot with its rear-intensive or echo attenuation as the main basis for the diagnosis were observed in patients with alanine aminotransferase and serum triglyceride equivalents.
Treatment:
(1) the composition of the treatment group Recipe: Dangshen 12 grams, 9 grams Atractylodes, Poria 9 grams, 15 grams of Coix Seed, Alisma 9 grams, 6 grams of Bupleurum, Coptis 6 g, Danshen 9 grams, 30 grams of Bletilla striata, Cassia 30 grams. GPT increased in Canada sarmentosum 30 grams, marked by elevated blood lipids plus 15 grams of Hawthorn, liver tenderness, who added 9 grams of Corydalis. 1 day, divided into morning and evening twice orally.
(2) control group was treated with Duoxikang capsules 1.8 grams of vitamin C 0.3 g three times a day; gemfibrozil capsules 0.6 grams, twice a day. The two groups are 60 days for a course of treatment, continuous treatment of two courses. During treatment, eating low-fat diet, temperance, alanine aminotransferase were elevated to proper rest.
Clinical criteria:
(1) clinical cure: B super showing normal liver morphology, ALT normal, decreased or normal blood lipids.
(2) markedly effective: B-ultrasonic examination showed a marked improvement of liver-spot-intensive, its rear echo attenuation significantly reduced, ALT normal decline in blood lipids.
(3) Effective: B-ultrasonic examination showed mild improvement of liver fat-like change, blood lipids down.
(4) is not valid: does not meet the effective standards.
Treatment outcomes: treatment group 42 cases, the clinical cure in 10 cases, effective in 22 cases, effective in 6 cases, 4 cases. The total effective rate was 90.5%. The control group of 40 patients, the clinical cure in 4 cases, markedly effective in 14 cases, effective in 8 cases, ineffective in 14 cases. The total effective rate was 65.0%.
Statistical analysis between the two groups are very significant differences. Fatty liver is generally considered benign lesions, prognosis is good. But that the development of fatty liver can be directly through the development of liver inflammation fibrosis, about 25% of the final development of fatty liver hepatitis fibrosis.
Most of the treatment of lipid-lowering drugs with the promotion of blood lipid metabolism in the liver excrete into the role of medication improperly can easily lead to liver damage and liver fat deposition increased. Therefore, drug selection should be more cautious, relatively speaking, Chinese medicine in drug safety has some advantages.